Item 7.01. Regulation FD Disclosure.
Oscar Health, Inc. (the "Company") will participate in the 2026 Raymond James Institutional Investors Conference (the "Conference") on March 2, 2026. At the Conference, the Company will reaffirm the full year 2026 guidance that it provided in its financial results press release for the fourth quarter and full-year 2025, dated February 10, 2026.
This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in any such filing.